| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 09/27/2000 | CN1056836C 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles and producing process thereof and their use as medicaments |
| 09/27/2000 | CN1056835C Novel selective aromatase inhibiting compounds |
| 09/26/2000 | US6124469 Process for preparing sulphurous 2-chloro-3-(4,5-dihydroisoxazol-3-yl)-benzoic acids |
| 09/26/2000 | US6124251 Toilet bowl cleaning tablet |
| 09/21/2000 | WO2000054759A2 Lxr modulators |
| 09/21/2000 | CA2367595A1 Lxr modulators |
| 09/20/2000 | EP1036060A2 Cyclohexadiene-derivatives as pesticides |
| 09/20/2000 | EP1035843A2 I h?-MODULATORS |
| 09/19/2000 | US6121479 Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics |
| 09/19/2000 | US6121281 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use |
| 09/19/2000 | CA2184914C Isoxazoline compounds as 5-lipoxygenase inhibitors |
| 09/14/2000 | WO2000053168A2 Synergy between low molecular weight heparin and platelet aggregation inhibitors, for preventing and treating thromboembolic disorders |
| 09/14/2000 | WO2000037422A3 Ion channel modulating agents |
| 09/14/2000 | CA2364252A1 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders |
| 09/13/2000 | EP0763017B1 N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors |
| 09/13/2000 | EP0691962B1 1-amino-3-phenoxy propane derivatives as modulators of multi-drug resistance |
| 09/12/2000 | CA2203138C Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents |
| 09/06/2000 | CN1265645A Urokinase inhibitors |
| 09/06/2000 | CN1265643A Anthranilic acid analogs |
| 09/05/2000 | US6114538 2-position of benzoy ring of 4-benzoylisoxazole derivative is substituted and particularly used against monocotyledonous weeds by post-emeregenece application |
| 09/05/2000 | US6114367 Such as 3-(3-cyclopentyloxy-4-methoxy)phenyl-2-isoxazoline-5-hydroxamic acid; treating sepsis, septic shock, inflammatory bowel disease, tuberculosis, graft versus host disease or cachexia associated with aids or cancer in a mammal |
| 09/05/2000 | US6114328 Isoxazoline and isoxazole fibrogen receptor antagonists |
| 09/05/2000 | US6114175 Amyloid-binding compounds which are non-azo derivatives of chrysamine g to determine degree of brain deposits quantitatively characterized by amyloidosis; down's syndrome; prevent cell degeneration; radioactive imaging |
| 08/31/2000 | WO2000050411A1 Method crystallising n-(4-trifluoromethylphenyl)-5-methyl-isoxazole-4-carboxamide |
| 08/31/2000 | WO2000050410A1 Isoxazoline compounds and processes for the preparation thereof |
| 08/31/2000 | WO2000019994A9 Estrogen receptor ligands |
| 08/31/2000 | WO2000007996A3 Pyrazoles as estrogen receptor modulators |
| 08/31/2000 | DE19908527A1 Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid A process for crystallization of N- (4-trifluoromethylphenyl) -5-methyl-isoxazole-4-carboxamide |
| 08/30/2000 | EP1030840A1 Cyclic amine derivatives and their use as drugs |
| 08/29/2000 | US6110938 1-(arylthioalkyl, arylaminoalkyl or arylmethylenealkyl)-4-(heteroaryl)piperidines and related compounds useful as antipsychotics and analgesics |
| 08/24/2000 | WO2000049016A1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds |
| 08/24/2000 | WO2000049004A1 Process for the preparation of 6-(perfluoroalkyl) uracil compounds from urea compounds |
| 08/24/2000 | WO2000049003A1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds from carbamate compounds |
| 08/24/2000 | WO2000049002A1 Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils |
| 08/24/2000 | CA2364281A1 Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils |
| 08/24/2000 | CA2363000A1 Process for the preparation of 6-(perfluoroalkyl) uracil compounds from urea compounds |
| 08/24/2000 | CA2362996A1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds from carbamate compounds |
| 08/24/2000 | CA2362990A1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds |
| 08/23/2000 | EP1028941A2 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 08/23/2000 | EP0876334B1 Phenylacetic acid derivatives, process for their preparation and their use as pesticides and fungicides |
| 08/23/2000 | EP0805795B1 Novel aromatic amides, method for preparing and compositions containing same, and use thereof as pesticides |
| 08/23/2000 | CN1055686C Substituted benzisoxazole and benzisothaazole herbicidal agents |
| 08/22/2000 | US6107508 Convergent synthesis of α-aryl-β-ketonitriles |
| 08/22/2000 | US6107320 Hypotensive agents |
| 08/16/2000 | EP1027328A1 Substituted anilides |
| 08/16/2000 | EP1027048A2 Selective cyclooxygenase-2 inhibitors against premature labor |
| 08/16/2000 | EP0738259B1 Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them |
| 08/10/2000 | WO2000046184A1 N2-phenylamidine derivatives |
| 08/10/2000 | WO2000045799A2 Use of substituted isoxazol carboxylic acids and derivatives and novel substances |
| 08/10/2000 | DE19904389A1 Verwendung von substituierten Isoxazolcarbonsäuren und Derivate und neue Stoffe Use of substituted Isoxazolcarbonsäuren and derivatives and new materials |
| 08/09/2000 | EP1025086A1 Benzamidine derivatives as factor xa inhibitors |
| 08/09/2000 | EP1025085A1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof |
| 08/08/2000 | US6100263 Controlling animal pests or harmful fungi; 2-methoxyimino-2-(2'-(1?-methyl,1?-(1?'-(6??-(4??'-chlorophenyl) -hexyloxyimino) ,2?',2?'-dimethylpropyl))iminooxymethyl)-phenylacetic acid monomethylamide, for example |
| 08/08/2000 | US6100260 Isoxazole derivatives |
| 08/08/2000 | CA2185019C Isoxazoline compounds as inhibitors of tnf release |
| 08/03/2000 | WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS |
| 08/03/2000 | DE19903126A1 New sulphur substituted sulphonylaminocarboxylic acid N-arylamide derivatives used for treating e.g. cardiovascular diseases and atherosclerosis |
| 08/03/2000 | CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 08/02/2000 | EP1023274A1 An efficient method for the conversion of nitriles to amidines |
| 08/02/2000 | CN1261906A Alkyl, alkenyl and alkynyl chrysamine G derivatives for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 08/01/2000 | US6096771 Isoxazole derivatives |
| 08/01/2000 | US6096768 Administering a 3, 5, 6-substituted phenyl compound for the treatment of inflammation and autoimmune disorders |
| 08/01/2000 | US6096741 Oxime derivatives, hydrazone derivatives and use thereof |
| 07/27/2000 | WO2000043354A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2357781A1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/26/2000 | EP1021413A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/26/2000 | EP1021410A1 Prostaglandin agonists and their use to treat bone disorders |
| 07/25/2000 | US6093736 Antibacterial agents |
| 07/25/2000 | US6093733 Muscarinic receptor agonists |
| 07/20/2000 | WO2000041474A2 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/20/2000 | WO2000029406A3 Novel isoxazoline fibrinogen receptor antagonists |
| 07/20/2000 | CA2359365A1 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/19/2000 | EP1019384A1 3-amino-1,2-benzoisoxazole derivatives, process for preparation, and use thereof |
| 07/19/2000 | EP1019380A2 Tricyclic 3-oxo-propanenitrile compounds |
| 07/19/2000 | EP0674626B1 Selective aromatase inhibiting compounds |
| 07/18/2000 | US6090836 Benzisoxazole-derived antidiabetic compounds |
| 07/12/2000 | EP0613468B1 Substituted salicylic acids for the treatment of autoimmune diseases |
| 07/12/2000 | CN1259942A Novel guanidine mimics as factor Xa inhibitors |
| 07/12/2000 | CN1259940A Crystalline roxifiban |
| 07/06/2000 | WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 07/06/2000 | WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
| 07/06/2000 | WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 07/06/2000 | WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 07/06/2000 | WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | CA2356929A1 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/05/2000 | EP1014962A1 Antithrombotic agents |
| 07/05/2000 | EP0675886B1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists |
| 07/05/2000 | CN1259121A Novel sulfonamide derivatives |
| 07/04/2000 | US6084130 For treatment of central nervous system disorders |
| 06/29/2000 | WO2000037422A2 Ion channel modulating agents |